[1]
2017. New treatment for non-Hodgkin B-cell lymphomas with a special focus on the impact of junctional adhesion molecules. Swiss Medical Weekly. 147, 3738 (Sep. 2017), w14487. DOI:https://doi.org/10.4414/smw.2017.14487.